ezetimibe has been researched along with bay 58-2667 in 1 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (bay 58-2667) | Trials (bay 58-2667) | Recent Studies (post-2010) (bay 58-2667) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 104 | 6 | 69 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Jia, A; Jiang, H; Liu, W; Sun, J; Xu, Q; Zhang, R | 1 |
1 other study(ies) available for ezetimibe and bay 58-2667
| Article | Year |
|---|---|
Novel application potential of cinaciguat in the treatment of mixed hyperlipidemia through targeting PTL/NPC1L1 and alleviating intestinal microbiota dysbiosis and metabolic disorders.
Topics: Cholesterol; Dysbiosis; Ezetimibe; Gastrointestinal Microbiome; Humans; Hyperlipidemias; Lipase; Lipidoses; Membrane Transport Proteins; Triglycerides | 2023 |